Showing results (81-90 of 100) with videos related to
Sort By:
Pageof 10
Scientific Reports|October 13, 2016
Impact of feline AIM on the susceptibility of cats to renal diseaseRyoichi Sugisawa, Emiri Hiramoto, Shigeru Matsuoka, et al.Cell Metabolism|August 2, 2005
A role for the apoptosis inhibitory factor AIM/Spalpha/Api6 in atherosclerosis developmentSatoko Arai, John M Shelton, Mingyi Chen, et al.Kidney360|May 22, 2026
Apoptosis Inhibitor of Macrophage and Acute Inflammation in IgA NephropathyRina Kato, Hitoshi Suzuki, Ryosuke Aoki, et al.Communications Biology|August 3, 2022
Two independent modes of kidney stone suppression achieved by AIM/CD5L and KIM-1Kyohei Matsuura, Natsumi Maehara, Aika Hirota, et al.Scientific Reports|July 27, 2017
Apoptosis inhibitor of macrophage ameliorates fungus-induced peritoneal injury model in miceTakako Tomita, Satoko Arai, Kento Kitada, et al.Veterinary Journal (London, England : 1997)|January 4, 2026
A clinical impact of apoptosis inhibitor of macrophage on feline chronic kidney diseaseTetsushi Tezuka, Hiroyuki Arakawa, Kai Kudo, et al.Clinical and Experimental Nephrology|February 6, 2016
Association of apoptosis inhibitor of macrophage (AIM) expression with urinary protein and kidney dysfunctionMegumi Oshima, Yasunori Iwata, Kengo Furuichi, et al.Cell Metabolism|June 4, 2010
Macrophage-derived AIM is endocytosed into adipocytes and decreases lipid droplets via inhibition of fatty acid synthase activityJun Kurokawa, Satoko Arai, Katsuhiko Nakashima, et al.Scientific Reports|December 9, 2016
A proteolytic modification of AIM promotes its renal excretionTomoko Yamazaki, Ryoichi Sugisawa, Emiri Hiramoto, et al.Journal of Autoimmunity|January 30, 2025
Pulmonary and serum cytokine profiles of patients with anti-ARS and anti-MDA5 antibodiesKazuhiro Kurasawa, Satoko Arai, Yumeko Taniguchi-Namiki, et al.Pageof 10